ITER study of patients with haemophilia A and factor VIII inhibitors

被引：0
|
作者：
Holstein, K. [1 ]
Klamroth, R. [2 ,3 ]
von Depka, M. [4 ]
Gringeri, A. [5 ,6 ]
Lambert, T. [7 ]
Lopez-Fernandez, M. [8 ]
Diniz, M. J. [9 ]
Rocino, A. [10 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, D-20246 Hamburg, Germany
[2] Vivantes Klinikum Friedrichshain, Innere Med Klin, Berlin, Germany
[3] Vivantes Klinikum Friedrichshain, Hamophiliezentrum, Berlin, Germany
[4] Werlhof Inst, Hannover, Germany
[5] Mangiagalli & Regina Elena Hosp Fdn, IRCCS Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[6] Univ Milan, I-20122 Milan, Italy
[7] Hop Bicetre, AP HP, Ctr Traitement Hemophiles, Le Kremlin Bicetre, France
[8] Complexo Hosp Univ A Coruna, Serv Hematol & Hemotherapia, Thrombosis & Haemostasis Unit, La Coruna, Spain
[9] Hosp San Jose, Ctr Hosp Lisboa Cent, Serv Imuno Hemoterapia, Lisbon, Portugal
[10] San Giovanni Bosco Hosp, Hemophilia & Thrombosis Ctr, Naples, Italy
来源：
HAMOSTASEOLOGIE | 2010年 / 30卷 / 4A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S46 / S47
页数：2
相关论文
共 50 条
  • [31] The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A
    Wang, X. F.
    Zhao, Y. Q.
    Yang, R. C.
    Wu, J. S.
    Sun, J.
    Zhang, X. S.
    Ding, Q. L.
    Ge, H. L.
    Wang, H. L.
    HAEMOPHILIA, 2010, 16 (04) : 632 - 639
  • [32] The in vitro procoagulant effect of recombinant porcine factor VIII in patients with inherited haemophilia A and inhibitors
    Dargaud, Yesim
    Nougier, Christophe
    Desage, Stephanie
    Meunier, Sandrine
    Lienhart, Anne
    HAEMOPHILIA, 2022, 28 : 40 - 41
  • [33] Factor VIII inhibitors in mild and moderate-severity haemophilia A
    Hay, CRM
    HAEMOPHILIA, 1998, 4 (04) : 558 - 563
  • [34] Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A
    van Helden, P. M. W.
    Kaijen, P. H. P.
    Mauser-Bunschoten, E. P.
    Fischer, K.
    van den Berg, H. M.
    Voorberg, J.
    HAEMOPHILIA, 2010, 16 (06) : 892 - 901
  • [35] Laboratory testing for factor VIII and IX inhibitors in haemophilia: A review
    Miller, C. H.
    HAEMOPHILIA, 2018, 24 (02) : 186 - 197
  • [36] The concept of idiotypic vaccination against factor VIII inhibitors in haemophilia A
    Lacroix-Desmazes, S
    Bayry, J
    Misra, N
    Kaveri, SV
    Kazatchkine, MD
    HAEMOPHILIA, 2002, 8 : 55 - 59
  • [37] Prevalence of factor VIII inhibitors with clinical relevance in haemophilia treatment
    Pollman, H
    Richter, H
    BLOOD, 1996, 88 (10) : 1308 - 1308
  • [38] Factor VIII inhibitors in mild and moderate-severity haemophilia A
    Hay, CRM
    Ludlam, CA
    Colvin, BT
    Hill, FGH
    Preston, FE
    Wasseem, N
    Bagnall, R
    Peake, IR
    Berntorp, E
    Bunschoten, EPM
    Fijnvandraat, K
    Kasper, CK
    White, G
    Santagostino, E
    THROMBOSIS AND HAEMOSTASIS, 1998, 79 (04) : 762 - 766
  • [39] A MULTIPLE ASCENDING DOSE STUDY OF MIM8 IN PATIENTS WITH SEVERE HAEMOPHILIA A WITH OR WITHOUT FACTOR VIII INHIBITORS
    Lentz, S. R.
    Chowdary, P.
    Lopez-Jaime, F. J.
    Mahlangu, J.
    Matytsina, I.
    Nielsen, A. L.
    Windyga, J.
    HAEMOPHILIA, 2023, 29 : 60 - 60
  • [40] Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study
    Ettingshausen, Carmen Escuriola
    Katsarou, Olga
    Kotnik, Barbara Faganel
    Derlon, Annie Borel
    Schwarz, Rudolf
    Ypma, Paula F.
    Matytsina, Irina
    Dey, Sohan
    Schutgens, Roger E. G.
    HAEMOPHILIA, 2022, 28 (01) : 46 - 54
12345